TNF and psoriasis: The UK study in 2015 (British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)) and US study in 2016 (PSOLAR) compared the drug survival of TNF-α and IL-12/23 inhibitors in patients with psoriasis.